Spatiotemporal Expression of Matrix Metalloproteinases (MMPs) is Regulated by the Ca2+-Signal Transducer S100A4 in the Pathogenesis of Thoracic Aortic Aneurysm

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Cao, Jiumei ^a   Geng, Liang ^a   Wu, Qihong ^a   Wang, Wei ^a   Chen, Qiujing ^a   Lu, Lin ^a   Shen, Weifeng ^a   Chen, Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CALCIUM ION; CALVASCULIN; CD68 ANTIGEN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA;

ADULT; ADVENTITIA; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; ARTERIAL WALL THICKNESS; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; THORACIC AORTIC ANEURYSM; TISSUE DISTRIBUTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; S100 PROTEINS; TRANSCRIPTION FACTOR RELA;

EID: 84880839247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070057     Document Type: Article

References (26)

1. Lindsay ME, Dietz HC, (2011) Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 473: 308-316.
2. Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, et al. (2008) Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 9: 283-302.
3. Cao J, Gong L, Guo DC, Mietzsch U, Kuang SQ, et al. (2010) Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice. Hum Mol Genet 19: 1908-1920.
4. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, et al. (2007) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39: 1488-1493.
5. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA, Jr., et al. (1998) Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 98: II331-337; discussion II337-338.
6. Jones JA, Barbour JR, Lowry AS, Bouges S, Beck C, et al. (2006) Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm. J Vasc Surg 44: 1314-1321.
7. Geng L, Wang W, Chen Y, Cao J, Lu L, et al. (2010) Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model. Exp Mol Pathol 89: 72-81.
8. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, et al. (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110: 625-632.
9. Xiong W, Knispel RA, Dietz HC, Ramirez F, Baxter BT (2008) Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J Vasc Surg 47: 166-172; discussion 172.
10. Chung AW, Yang HH, Radomski MW, van Breemen C, (2008) Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and-9. Circ Res 102: e73-85.
11. Boye K, Maelandsmo GM, (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176: 528-535.
12. Barak Y, Juven T, Haffner R, Oren M, (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468.
13. Bian J, Sun Y, (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17: 6330-6338.
14. Engelkamp D, Schafer BW, Erne P, Heizmann CW, (1992) S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart. Biochemistry 31: 10258-10264.
15. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, et al. (1999) S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 59: 4702-4708.
16. Senolt L, Grigorian M, Lukanidin E, Simmen B, Michel BA, et al. (2006) S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis 65: 1645-1648.
17. Schmidt-Hansen B, Ornas D, Grigorian M, Klingelhofer J, Tulchinsky E, et al. (2004) Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23: 5487-5495.
18. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, et al. (2007) Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 100: 1055-1062.
19. Greenway S, van Suylen RJ, Du Marchie Sarvaas G, Kwan E, Ambartsumian N, et al. (2004) S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 164: 253-262.
20. Zhang X, Shen YH, LeMaire SA, (2009) Thoracic aortic dissection: are matrix metalloproteinases involved? Vascular 17: 147-157.
21. Klingelhofer J, Senolt L, Baslund B, Nielsen GH, Skibshoj I, et al. (2007) Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis and rheumatism 56: 779-789.
22. Heizmann CW, Fritz G, Schafer BW, (2002) S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-1368.
23. Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, et al. (2001) S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A 98: 13889-13894.
24. Pietzsch J, Hoppmann S, (2009) Human S100A12: a novel key player in inflammation? Amino Acids 36: 381-389.
25. Oslejskova L, Grigorian M, Gay S, Neidhart M, Senolt L, (2008) The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 67: 1499-1504.
26. Kuivaniemi H, Platsoucas CD, Tilson MD, 3rd (2008) Aortic aneurysms: an immune disease with a strong genetic component. Circulation 117: 242-252.